Page 28 - ARUBA TODAY
P. 28

A28    SCIENCE
                Friday 17 November 2017


















             U.S. health agency to crack down on risky stem cell offerings


            By MATTHEW PERRONE                                                                                                  procedures  for  heart  dis-
             AP Health Writer                                                                                                   ease,  Parkinson’s  disease
            WASHINGTON  (AP)  —  U.S.                                                                                           and other conditions. And
            health    authorities   an-                                                                                         U.S.  marshals,  under  FDA
            nounced  plans  Thursday                                                                                            instructions,  seized  vials  of
            to crack down on doctors                                                                                            an unproven vaccine from
            pushing  stem  cell  proce-                                                                                         StemImmune  Inc.  of  San
            dures  that  pose  the  grav-                                                                                       Diego.
            est risks to patients amid an                                                                                       The FDA’s authority to reg-
            effort to police a burgeon-                                                                                         ulate stem cell procedures
            ing medical field that pre-                                                                                         is  a  murky  area  that  has
            viously  has  received  little                                                                                      been debated for years.
            oversight.                                                                                                          Typically the agency does
            The Food and Drug Admin-                                                                                            not   regulate   individual
            istration laid out a strategy                                                                                       doctors  or  their  in-office
            for  regulating  cell-based                                                                                         procedures,  focusing  in-
            medicine,  including  hun-                                                                                          stead  on  products  devel-
            dreds of private clinics that                                                                                       oped by drug and medical
            have  opened  across  the                                                                                           device manufacturers. But
            nation in the last decade.                                                                                          FDA has asserted its author-
            Many  of  the  businesses     In this Dec. 5, 2014 file photo, a doctor injects a patient with a solution he says is rich in adult stem   ity  in  certain  cases  when
            promote  stem  cell  injec-  cells, at his practice in Beverly Hills, Calif.                                        doctors  begin  processing
            tions for dozens of diseases                                                                       Associated Press  stem  cells  and  marketing
            including  arthritis,  multiple   Gottlieb  said  the  agency  cells  from  bone  marrow   stream.                  them  to  treat  serious  dis-
            sclerosis and even Alzheim-  plans  to  use  discretion  in  transplants have long been   In  August  the  FDA  took   eases.
            er’s.  They  can  cost  $5,000   overseeing  lower-risk  pro-  used to treat leukemia and   action  against  clinics  in   Guidelines  released  by
            to $50,000, but there’s little   cedures  such  as  injections  other blood diseases.  Florida and California. The   the  agency  Thursday  aim
            research  that  such  proce-  for achy joints, adding that  Most of the new clinics of-  agency  issued  a  warning   to  clarify  how  much  pro-
            dures are safe or effective.  this  approach  would  al-  fer  adults  stem  cells  isolat-  letter  to  Sunrise,  Florida-  cessing  cells  can  under-
            Researchers for years have   low the agency to get the  ed  from  fat.  Practitioners   based  US  Stem  Cell  Clinic   go  before  triggering  FDA
            called  for  a  crackdown.   “most  bang  for  our  regu-  collect  the  fluid  from  pa-  for marketing unapproved   regulation.q
            FDA  officials  said  they  will   latory  buck.”  He  also  said  tients  via  liposuction,  treat
            focus  their  enforcement    the  agency  needs  to  be  it with chemicals and then
            efforts  on  “bad  actors”   “nimble  and  creative”  in  inject it back into the body
            who  inject  stem  cell  mix-  its regulation to encourage  to treat various conditions.
            tures into the bloodstream,   legitimate  researchers  in  Three Florida women were
            nervous  system  or  eyes.   the field.                   left  nearly  or  completely
            Regulators  say  those  pro-  Stem cells have long been  blind  by  one  such  fat-
            cedures  pose  the  biggest   recognized  for  their  abil-  based procedure, accord-
            risk to patients.            ity  to  reproduce  and  re-  ing  to  a  report  published
            “We’re  going  to  be  priori-  generate tissue. And while  earlier this year in the New
            tizing places where we see   emerging  research  sug-     England  Journal  of  Medi-
            products  —  not  just  being   gests  that  they  will  even-  cine.  The  Florida  Medical
            promoted  inappropriately    tually  be  used  to  treat  a  board  previously  revoked
            —  but  putting  patients  at   range  of  debilitating  dis-  the license of another stem
            potential  risk,”  FDA  Com-  eases,  they  are  currently  cell  practitioner  after  two
            missioner  Scott  Gottlieb   only approved for a hand-    patients  died  under  his
            told reporters on a confer-  ful of medical procedures.  care after receiving IV drips
            ence call.                   For  instance,  adult  stem  of stem cells to the blood-
   23   24   25   26   27   28   29   30   31   32